A detailed history of New Edge Advisors, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, New Edge Advisors, LLC holds 83,479 shares of BSX stock, worth $7.43 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
83,479
Previous 81,307 2.67%
Holding current value
$7.43 Million
Previous $6.26 Million 11.72%
% of portfolio
0.05%
Previous 0.05%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.96 - $84.0 $158,469 - $182,448
2,172 Added 2.67%
83,479 $7 Million
Q2 2024

Aug 15, 2024

BUY
$67.33 - $77.71 $1.39 Million - $1.6 Million
20,644 Added 34.03%
81,307 $6.26 Million
Q1 2024

May 14, 2024

BUY
$57.6 - $68.62 $1.13 Million - $1.34 Million
19,573 Added 47.63%
60,663 $4.15 Million
Q4 2023

Feb 13, 2024

SELL
$48.64 - $57.81 $489,172 - $581,395
-10,057 Reduced 19.66%
41,090 $2.38 Million
Q3 2023

Nov 14, 2023

BUY
$50.19 - $54.68 $934,989 - $1.02 Million
18,629 Added 57.29%
51,147 $2.7 Million
Q2 2023

Aug 14, 2023

BUY
$49.72 - $54.64 $101,478 - $111,520
2,041 Added 6.7%
32,518 $1.76 Million
Q1 2023

May 12, 2023

BUY
$45.09 - $50.03 $218,100 - $241,995
4,837 Added 18.87%
30,477 $1.52 Million
Q4 2022

Feb 14, 2023

BUY
$39.56 - $47.22 $137,589 - $164,231
3,478 Added 15.69%
25,640 $1.19 Million
Q3 2022

Nov 14, 2022

SELL
$36.71 - $109.66 $147,207 - $439,736
-4,010 Reduced 15.32%
22,162 $858,000
Q2 2022

Aug 09, 2022

BUY
$35.24 - $47.1 $463,511 - $619,506
13,153 Added 101.03%
26,172 $976,000
Q1 2022

May 13, 2022

SELL
$40.9 - $45.1 $153,906 - $169,711
-3,763 Reduced 22.42%
13,019 $577,000
Q4 2021

Feb 17, 2022

BUY
$38.07 - $44.87 $45,303 - $53,395
1,190 Added 7.63%
16,782 $713,000
Q3 2021

Oct 29, 2021

BUY
$41.23 - $45.88 $349,671 - $389,108
8,481 Added 119.27%
15,592 $677,000
Q2 2021

Jul 22, 2021

BUY
$38.58 - $44.24 $274,342 - $314,590
7,111 New
7,111 $304,000
Q4 2020

Jan 27, 2021

SELL
$33.15 - $41.97 $363,788 - $460,578
-10,974 Closed
0 $0
Q3 2020

Nov 03, 2020

BUY
$34.44 - $42.23 $18,873 - $23,142
548 Added 5.26%
10,974 $419,000
Q2 2020

Jul 29, 2020

BUY
$30.19 - $39.11 $50,477 - $65,391
1,672 Added 19.1%
10,426 $366,000
Q1 2020

May 04, 2020

SELL
$25.83 - $45.71 $47,992 - $84,929
-1,858 Reduced 17.51%
8,754 $286,000
Q4 2019

Jan 31, 2020

SELL
$37.87 - $45.37 $32,038 - $38,383
-846 Reduced 7.38%
10,612 $479,000
Q3 2019

Nov 06, 2019

BUY
$40.31 - $43.45 $84,691 - $91,288
2,101 Added 22.45%
11,458 $464,000
Q2 2019

Aug 05, 2019

BUY
$34.91 - $42.98 $47,617 - $58,624
1,364 Added 17.06%
9,357 $402,000
Q1 2019

May 14, 2019

BUY
$32.91 - $40.75 $263,049 - $325,714
7,993 New
7,993 $307,000
Q1 2019

May 09, 2019

SELL
$32.91 - $40.75 $266,274 - $329,708
-8,091 Closed
0 $0
Q4 2018

Jan 29, 2019

BUY
$31.73 - $39.04 $5,457 - $6,714
172 Added 2.17%
8,091 $286,000
Q3 2018

Oct 29, 2018

BUY
$32.83 - $38.63 $259,980 - $305,910
7,919 New
7,919 $305,000
Q3 2017

Nov 13, 2017

SELL
$26.26 - $29.17 $63,365 - $70,387
-2,413 Closed
0 $0
Q2 2017

Aug 16, 2017

BUY
N/A
2,413
2,413 $0

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $127B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.